NEUROBUDS Trademark

Trademark Overview


On Thursday, June 13, 2024, a trademark application was filed for NEUROBUDS with the United States Patent and Trademark Office. The USPTO has given the NEUROBUDS trademark a serial number of 79401545. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Wednesday, December 18, 2024. This trademark is owned by T&W Engineering A/S. The NEUROBUDS trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments for diagnostic and monitoring purposes

General Information


Serial Number79401545
Word MarkNEUROBUDS
Filing DateThursday, June 13, 2024
Status640 - NON-FINAL ACTION COUNTED - NOT MAILED
Status DateWednesday, December 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized wording "NEUROBUDS".
Pseudo MarkNEURO BUDS
Goods and ServicesMedical apparatus and instruments for diagnostic and monitoring purposes

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, August 8, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameT&W Engineering A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events


Event DateEvent Description
Thursday, August 8, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, August 15, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, December 18, 2024NON-FINAL ACTION WRITTEN
Wednesday, December 18, 2024ASSIGNED TO EXAMINER
Thursday, August 15, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 7, 2024NEW REPRESENTATIVE AT IB RECEIVED